Removal of ovaries for young women with breast cancer and family history of ovarian cancer

August 27, 2002

Women diagnosed with breast cancer at a young age who have a family history of either breast or ovarian cancer have a substantially increased risk of developing ovarian cancer compared with women with breast cancer without a family history of either disease, suggest authors of a study published on THE LANCET's website today--www.thelancet.com. Authors of the study recommend that close medical surveillance--and perhaps even removal of the ovaries--might be justified for women at the greatest risk of ovarian cancer.

Around 1% of women in northern Europe and the USA are at risk of ovarian cancer before 70 years of age; the risk is smaller in other developed countries and in less-developed settings. Previous research has suggested that women with breast cancer have a small increased risk of ovarian cancer; this risk is greatly increased in the presence of specific gene mutations (BRCA1 AND BRCA2). However, these gene mutations do not account for all familial breast or ovarian cancers, which (combined with the absence of genetic screening programmes) suggest that other factors--for example the age at onset of breast cancer, and information about a family history of breast or ovarian cancer--might be more useful to identify women with breast cancer at the greatest risk of ovarian cancer.

Kjell Bergfeldt and colleagues from the Karolinska Institute, Stockholm, Sweden, identified over 30,000 women under 70 years of age who had been diagnosed with breast cancer. The investigators obtained information about breast cancer and ovarian cancer for around 146,000 first-degree relatives (parents, siblings, children) of the study population.

After an average of six years follow-up, women with breast cancer were twice as likely to have ovarian cancer than women in the general Swedish population. Diagnosis of breast cancer before 40 years of age substantially increased the risk of ovarian cancer. Women with breast cancer who did not have a family history of either breast or ovarian cancer had a 60% relative increase in risk of ovarian cancer compared with the general population. Women with a family history of either disease were at a much greater risk of ovarian cancer than the general population (five to sixfold increased risk for a family history of breast cancer, and a seventeen-fold increased risk for a family history of ovarian cancer).

Kjell Bergfeldt comments: "The clinical implications of our findings are not obvious, especially because there is no effective screening strategy for ovarian cancer. However, provided that our results are confirmed by other investigators, they seem to allow identification, based on easily obtained clinical information, of a small subgroup of women with breast cancer who are at particularly high risk of ovarian cancer. In this subgroup, counselling, and perhaps even prophylactic oophorectomy, might be considered."
-end-
Contact: Dr Kjell Bergfeldt, Department of Medical Epidemiology, Karolinska Institute, Box 281, S-171 77 Stockholm, Sweden; T) +46 8 517 70000; M) +46 70 626 56 19; F) +46 8 314 975; E) Kjell.Bergfeldt@mep.ki.se

Lancet

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.